P. Bürgisser

发表

Prevalence of human T‐cell leukemia virus types I and II in Switzerland

L. Perrin, J. Böni, W. Fierz, 2004, Journal of medical virology.

Assessment of Recent HIV-1 Infection by a Line Immunoassay for HIV-1/2 Confirmation

P. Vernazza, S. Yerly, G. Martinetti, 2007, PLoS medicine.

HIV-1 drug resistance transmission networks in southwest Switzerland.

S. Yerly, G. Pantaleo, M. Cavassini, 2010, AIDS research and human retroviruses.

The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland.

H. Günthard, R. Weber, M. Battegay, 2011, The Journal of infectious diseases.

Severe interference between retinal angiography and automated four‐color flow cytometry analysis of blood mononuclear cells

P. Bart, J. Vaudaux, P. Bürgisser, 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Lipid synthesis by oligodendrocytes from adult pig brain maintained in long-term culture

H. Althaus, V. Neuhoff, P. Bürgisser, 1988, Neurochemistry International.

Expression of myelin proteins characteristic of fish and tetrapods by Polypterus revitalizes long discredited phylogenetic links

J. Malotka, T. Waehneldt, J. Matthieu, 1986, Brain Research.

Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load

A. Telenti, H. Günthard, M. Battegay, 2010, PLoS pathogens.

Prolonged seroconversion in an elite controller of HIV-1 infection.

M. Cavassini, J. Böni, O. Clerc, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

high Frequency of Non-b Subtypes in Newly Diagnosed Hiv-1 Infections in Switzerland

M. Zwahlen, L. Perrin, J. Böni, 1999 .

Myelin lipids: A phylogenetic study

T. Waehneldt, J. Matthieu, G. Jeserich, 1986, Neurochemical Research.

Comparison of a competitive combined reverse transcription-PCR assay with a branched-DNA assay for hepatitis C virus RNA quantitation

D. Lavanchy, C. Mayerat, A. Mantegani, 1996, Journal of clinical microbiology.

Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases

P. Frei, P. Bürgisser, R. Kämmerer, 1995, Clinical and diagnostic laboratory immunology.

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.

A. Telenti, H. Günthard, M. Battegay, 2007, Archives of internal medicine.

In vivo labeling of myelin lipids and proteolipid protein with [3H]myristate, [14C]linoleate, and [14C]linolenate

P. Bürgisser, J. Matthieu, P. Bürgisser, 2004, Neurochemical Research.

Performance evaluation of a new fourth-generation HIV combination antigen–antibody assay

G. Pantaleo, H. Schennach, M. Axelsson, 2012, Medical Microbiology and Immunology.

Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants

S. Louisirirotchanakul, J. Echevarría, J. Helden, 2007, Medical Microbiology and Immunology.

Immune response to hepatitis B vaccination in HIV-positive adults with isolated antibodies to HBV core antigen.

M. Cavassini, K. Darling, L. Elzi, 2012, The Journal of infection.

Multicenter Evaluation of a New Automated Fourth-Generation Human Immunodeficiency Virus Screening Assay with a Sensitive Antigen Detection Module and High Specificity

A. Berger, H. Rabenau, C. Gabriel, 2002, Journal of Clinical Microbiology.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.

H. Günthard, M. Battegay, H. Furrer, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland

M. Cavassini, K. Darling, D. Moradpour, 2011, PloS one.

An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population

M. Cavassini, J. Izopet, K. Darling, 2013, PloS one.

Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV , Switzerland KENFAK-FOGUENA

J. Izopet, K. Darling, D. Moradpour, 2019 .

Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptase.

H. Günthard, S. Yerly, T. Klimkait, 2010, The Journal of infectious diseases.

Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase Inhibitors

H. Günthard, M. Battegay, P. Vernazza, 2011, Journal of Acquired Immune Deficiency Syndromes.

Multicenter evaluation of the elecsys® anti‐HCV II assay for the diagnosis of hepatitis C virus infection

G. Pantaleo, J. Esteban, H. Schennach, 2013, Journal of medical virology.

Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.

J. Bartel, R. Camacho, I. Zahn, 2006, Clinical laboratory.

Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

Beda Joos, Huldrych F. Günthard, Matthias Cavassini, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimating the basic reproductive number from viral sequence data.

Beda Joos, Tanja Stadler, Sebastian Bonhoeffer, 2012, Molecular biology and evolution.

African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study

H. Günthard, S. Yerly, T. Klimkait, 2009, AIDS.

HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy

T. Klimkait, L. Perrin, B. Ledergerber, 2008, AIDS.

Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection

H. Günthard, S. Yerly, T. Klimkait, 2012, BMC Infectious Diseases.

MBE methodology became available allowing for sequences being sampled sequentially through time ( Rambaut 2000 ) , allowing for changing population sizes through time (

H. Günthard, S. Yerly, T. Klimkait, 2018 .

Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.

Matthias Cavassini, Patrick Taffé, Sebastian Bonhoeffer, 2010, The Journal of infectious diseases.

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

Jörg Schüpbach, Sabine Yerly, Jürg Böni, 2007, AIDS.

Performance of Five Different Assays for the Quantification of Viral Load in Persons Infected With Various Subtypes of HIV‐1

P. Vernazza, G. Pantaleo, J. Böni, 2000, Journal of acquired immune deficiency syndromes.

Expansion of T cells negative for CD28 expression in hiv infection. Relation to activation markers and cell adhesion molecules, and correlation with prognostic markers

P. Frei, A. Iten, P. Bürgisser, 1996, Medical Microbiology and Immunology.

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.

L. Held, H. Günthard, P. Vernazza, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland.

P. Francioli, H. Günthard, M. Battegay, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients.

F. Spertini, P. Meylan, P. Bürgisser, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men

H. Günthard, R. Weber, S. Yerly, 2010, AIDS.

Spare non-occupational HIV post-exposure prophylaxis by active contacting and testing of the source person

A. Telenti, P. Francioli, Gilbert GREUB, 2002, AIDS.

Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient.

A. Telenti, P. Francioli, Gilbert GREUB, 2001, AIDS.

HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapy.

H. Günthard, S. Yerly, T. Klimkait, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: the Swiss HIV Cohort Study (SHCS)

H. Günthard, S. Yerly, T. Klimkait, 2009, HIV medicine.

Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study

H. Günthard, M. Battegay, P. Vernazza, 2011, Journal of Translational Medicine.